Search Within

Saad Zafar Usmani

  1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (103)
  2. Journal Article (28)
  3. Research Letter (6)
  4. Correspondence (3)
  5. Review (2)
  6. Guidelines (1)
Groups
  1. Hematologic Malignancies, Division of (143)
  2. Department of Medicine (137)
  3. Center for Hematologic Malignancies (135)
  4. Myeloma (131)
  5. Hematologic Malignancies Research (116)
  6. Survivorship Research (106)

More Groups

People
  1. Alexander Lesokhin (114)
  2. Sham Mailankody (99)
  3. Urvi Shah (99)
  4. Carlyn Rose Tan (93)
  5. Kylee Maclachlan (91)
  6. Malin Hultcrantz (91)

More People

Years
  1. 2025 (8)
  2. 2024 (45)
  3. 2023 (57)
  4. 2022 (33)
Publications
  1. Blood (47)
  2. Clinical Lymphoma, Myeloma and Leukemia (45)
  3. Journal of Clinical Oncology (15)
  4. Blood Advances (8)
  5. Blood Cancer Journal (8)
  6. American Journal of Hematology (2)

More Publications

Publishers
  1. American Society of Hematology (55)
  2. Elsevier Inc. (50)
  3. American Society of Clinical Oncology (15)
  4. Nature Publishing Group (10)
  5. American Association for Cancer Research (3)
  6. John Wiley & Sons, Inc. (2)

More Publishers

Results (143)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CMV reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma
    Meeting Abstract

    Jurgens, E.; Shekarkhand, T.; Rueda, C.; Nemirovsky, D.; Derkach, A.; Firestone, R.; Miller, K.; Costa, B.; Rajeeve, S.; Lesokhin, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed/refractory multiple myeloma
    Meeting Abstract

    Costa, B.; Rajeeve, S.; Jurgens, E.; Nishimura, N.; Farzana, T.; Firestone, R.; Miller, K.; Lesokhin, A.; Shah, G.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Real-world safety and early efficacy of talquetamab in patients with heavily-pretreated relapsed/refractory multiple myeloma
    Meeting Abstract

    Costa, B.; Tan, C.; Shekarkhand, T.; Firestone, R.; Jurgens, E.; Miller, K.; Lesokhin, A.; Shah, G.; Korde, N.; Rajeeve, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Maintenance therapy cessation for multiple myeloma patients with three-year sustained mrd negative remissions
    Meeting Abstract

    Korde, N.; Hassoun, H.; Landau, H.; Hamid, S.; Derkach, A.; Hultcrantz, M.; Mailankody, S.; Tan, C.; Shah, U.; Maclachlan, K.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Para-medullary (PMD) and extra-medullary (EMD) myeloma demonstrate increased copy number aberration, mutational burden, structural variants and genomic complexity compared to marrow-based myeloma
    Meeting Abstract

    Maclachlan, K.; Garcés, J. J.; Shekarkhand, T.; Rajeeve, S.; Hashmi, H.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Tan, C.; Mailankody, S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Artificial intelligence enabled interpretation of ECG images to predict hematopoietic cell transplantation toxicity
    Journal Article

    Shaffer, B. C.; Brown, S.; Chinapen, S.; Mangold, K. E.; Lahoud, O.; Lopez-Jimenez, F.; Schaffer, W.; Liu, J.; Giralt, S.; Devlin, S.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Genomic profiling to contextualize the results of intervention for smoldering multiple myeloma
    Journal Article

    Kazandjian, D.; Diamond, B.; Papadimitriou, M.; Hill, E.; Sklavenitis-Pistofidis, R.; Ziccheddu, B.; Blaney, P.; Chojnacka, M.; Durante, M.; Maclachlan, K.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma
    Research Letter

    Hultcrantz, M.; Hassoun, H.; Korde, N.; MacLachlan, K.; Mailankody, S.; Patel, D.; Shah, U. A.; Tan, C. R.; Chung, D. J.; Lahoud, O. B.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Diagnosis disclosure patterns among patients with plasma cell disorders
    Meeting Abstract

    Malik, M.; Dalvi, A.; Derkach, A.; Aldana, A. M. S. S.; Martinez, J. A. H.; Merlo, G.; Ahlstrom, J. M.; Hydren, J. R.; Usmani, S. Z.; Chimonas, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Supplement use habits and perceptions in patients with plasma cell disorders
    Meeting Abstract

    Leyfman, Y.; Schach, E.; Derkach, A.; Castro, F.; Martínez, J. A. H.; Aldana, A. M. S. S.; Pérez, P. A. F.; Malik, M.; Ahlstrom, J. M.; Hydren, J. R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save